Treatment of Skin and Soft Tissue Infections

Abstract

Get full access to this article

View all access options for this article.

References

Hook EW , Hooton TM , Horton C. , et al: Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 146:295-297,1986

Nelson J. , Ginsburg C. : An hypothesis on the pathogenesis of Haemophilus influeruae buccal cellulitis . J Pediatr 88:709-710, 1976

Granoff C. , Nankerves G. : Cellulitis due to HF type b antigenemia and antibody responses. Am J Dis Child 130:1211-1214,1976

Swartz MN : Cellulitis and superficial infections, in Mandell GL , Douglas RG , Bennett JE (eds): Principles and practice of infectious disease, (ed 3). New York, NY, Churchill Livingstone, 1990, pp 796-807

Magnussen CR : Skin and soft tissue infections, in Reese R , Douglas G (eds): A Practical Approach to Infectious Diseases, (ed 2), Boston, MA, Brown, 1983, pp 239-265

Dagan R. , Moshe P. , Watemberg N. , et al: Outpatient treatment of serious community-acquired pediatric infections using once daily intramuscular ceftriaxone. Pediatr Infect Dis J 6:1080-1084, 1987

Gould IM , Hudson M. , Morris J. , et al: Imipenem versus standard therapy in the treatment of serious soft tissue infection. Drugs Exp Clin Res 14:555-558, 1988

Kulhanjian J. , Dunphy M. , Hanstra S. , et al: Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children . Pediatr Infect Dis J 8:605-610,1989

Stromberg BV , Reines HD , Hunt P. : Comparative clinical study of sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues. Surg Gynecol Obstet 162:575-578,1986

10.

Ramirez-Ronda .CH , Saavedra S. , Rivera-Vazquez CR : Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections. Am J Med 82:220-223, 1987 (suppl 4A)

11.

Greenberg RN , Kennedy DJ , Reilly PM , et al: Treatment of bone, joint and soft-tissue infections with oral ciproloxacin. Antimicrob Agents Chemother 31:151-152, 1987

12.

LeFrock J. , Blais F. , Schell R. , et al: Cefoxitin in the treatment of diabetic patients with lower extremity infections. Infect Surg 2:361-374, 1983

13.

Fierer J. , Daniel D. , Davis C. : The fetid foot: Lower-extremity infections in patients with diabetes mellitus . Rev Infect Dis 1:210-217, 1979

14.

Hughes C. , Johnson C. , Bamberger D. , et al: Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: A randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime. Clin Ther 10:36-49, 1987 (suppl A)

15.

Thadepalli H. , Mathai D. , Chuah SK , et al: Ciprofloxacin versus ceftazidime in skin and soft tissue infections. J Chemother 1:30-34,1989

16.

Solomkin JS , Cocchetto DM : Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infections. Clin Ther 9:123-134, 1986

17.

Parish LC , Witkowski JA , Snow R. , et al: Cephalosporins in cutaneous infections. A prospective comparison of two dosage regimens of ceftazidime for therapy of skin and skin structure infections. Int J Dermatol 25:258-265, 1986

18.

Gentry LO , Ramirez-Ronda CH , Rodriguez-Noriega E. , et al: Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin structure infections. Arch Intern Med 149:2579-2583, 1989

19.

Gentry LO , Koshdel A. : Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure. Am J Med 87:132S-135S, 1989 (suppl 5A)

20.

Dominguez J. , Palma F. , Vega ME , et al: Brief report: Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections. Am J Med 87:136S-137S, 1989 (suppl 5A)

21.

Licitra CM , Brooks RG , Sieger BE : Clinical efficacy and levels of ciprofloxacin in tissue in patients with soft tissue infection. Antimicrob Agents Chemother 31:805-807, 1987

22.

Perez-Ruvalcaba JA , Quintero-Perez NP , Morales-Reyes JJ , et al: Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections. Am J Med 82:242-246,1987 (suppl 4A)

23.

Modai J. , The French Multicenter Study Group : Treatment of serious infections with intravenous ciprofloxacin. Am J Med 57:243-247, 1989 (suppl 5A)

24.

Neu HC , Davidson S. , Briones F. : Intravenous/oral ciprofloxacin therapy of infections caused by multiresistant bacteria. Am J Med 87:209-212, 1989 (suppl 5A)

25.

Katz S. , Klein J. , Yow M. , et al: Ampicillin resistant strains of HF type b. Pediatrics 55:145-146, 1975

26.

Slaughter R. , Pieper J. , Cerra F. , et al: Chloramphenicol sodium succinate kinetics in the critically ill patients. Clin Pharmacol Ther 28:69-77, 1982

27.

Kauffman R. , Tirumoosthi M. , Buckley J. , et al: Relative bioavailability of intravenous chloramphenicol succinate and oral chloramphenicol palmitate in infants and children. J Pediatr 99:963-967, 1981

28.

Marks M. , LaFerriere C. : Chloramphenicol: Recent developments and clinical indications. Clin Pharm 1:315-320, 1982

29.

Brasfield J. , Record K. , Griffen W. , et al: Chloramphenicol and chloramphenicol succinate concentration in patients with renal impairment. Clin Pharm 2:355-358, 1983

30.

Azzollini F. , Gazzanega A. , Lodola E. , et al: Elimination of chloramphenicol and thiamphenicol in subjects with cirrhosis of the liver. Int J Clin Pharmacol 6:130-143, 1976

31.

Palmer J. , Keith H. , Huang N. : Absorption of chloramphenicol palmitate in patients with cystic fibrosis. Cystic Fibrosis Club Proc 21:82, 1980

32.

Swartz M. : Lymphadenitis and lymphangitis, in Mandell GL , Douglas RG , Bennett JE (ed): Principles and Practice of Infectious Disease , (ed 3). New York, NY, Churchill Livingstone, 1990, pp 818-825

33.

Li K. , Wald ER : Use of rifampin in Haemophilits infirtenzae type b infections. Am J Dis Child 140:381-385, 1986

34.

Simmons RL , Ahrenholz DH : Infections of skin and soft tissues, in Simmons RL , Howard RJ (eds): Surgical infections. Nonvalk, CT, Appleton-Century-Crofts , 1982, pp 507-683

35.

Dajani AS , Garcia RE , Wolinski E. : Etiology of Lymphadenitis in children. N Engl J Med 268:1329-1341, 1963

36.

White AG : Medical disorders in drug addicts. JAMA 223:1469-1471, 1973

37.

Webb D. , Thadepalli H. : Skin and soft-tissue polymicrobial infections from intravenous abuse of drugs . West J Med 130:200-204, 1979

38.

Orangio GR , Pitlick SD , Latta PD , et al: Soft-tissue infections in parenteral drug abusers. Ann Surg 199:97-100, 1984

39.

Moustoukas N. , Nichols R. , Smith J. , et al: Contaminated street heroin. Relationship to clinical infections. Arch Surg 118:746-749, 1983

40.

Tuazon CV , Hill R. , Sheayren JN : Microbiologic study of street heroin and injection paraphernalia. J Infect Dis 1299:327-329, 1974 '

41.

Tuazon CV , Sheagren JN : Increased rate of carriage of Staphylococcus actrects among narcotic addicts . J Infect Dis 129:725-727, 1974

42.

Haw T. , Kallick C. : Surgical infection in drug addicts. World J Surg 4:403-413, 1980 . _

43.

Sudarsky LA , Laschinger JC , Coppa FG , et al: Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg 206:661-665, 1987

44.

Crane L. , Levine D. , Aervos M. , et al: Bacteremia in narcotic addicts at Detroit Medical Center. Microbiology, epidemiology, risk factors, and empiric therapy. Rev Infect Dis 8:364-373, 1986

45.

Markowitz N. , Pohlod D. , Saravolatz L. , et al: In vitro susceptibility patterns of methicillin-resistant and susceptible Staphylococcus aetreus strains in a population of parenteral drug abusers from 1972 to 1981. Antimicrob Agent Chemother 23:450-457, 1983

46.

King CH , Creger RJ , Ellner JJ : Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs . Antimicrob Agents Chemother 27:285-290, 1985

47.

Louria D. : Surgical infections in drug addicts. World J Surg 4:412-413, 1980 (invited commentary)

48.

Callaham M. : Dog bites. JAMA 244:2327-2328,1980

49.

Goldstein Ejc , Citron DM , Finegold SM : Role of anaerobic bacteria in bite wound infections. Rev Infect Dis 6:177-183, 1984 (suppl 1)

50.

Baile WE , Stowe EC , Schmitt AM : Aerobic bacterial flora of oral and nasal fluids of canines with reference to bacteria associated with bites. J Clin Microbiol 7:223-231, 1978

51.

Saphir DA , Carter GR : Gingival flora of the dog with special reference to bacteria associated with bites. J Clin Microbiol 3:344-349,1976

52.

Goldstein Ejc , Citron DM , Finegold SM : Dog bite wounds and infection: A prospective clinical study. Ann Emerg Med 9:508-512, 1980

53.

Rest JG , Goldstein Ejc : Management of human and animal bite wounds. Emerg Med Clin North Am 3:117126, 1985

54.

Man RJ , Hoffeld TA , Farmer CB : Human bites of the hand: Twenty years of experience. J Hand Surg 2:97-99, 1977

55.

Brook I. : Bacteriology study of paronychia in children. Am J Surg 141:703-705, 1981

56.

Nunley D. , Suski T. , Atkins A. , et al: Hand infections in hospitalized patients. Am J Surg 140:374-376, 1980

57.

Goldstein Ejc , Citron DM , Wield B. , et a]: Bacteriology of human and animal bite wounds. J Clin Microbiol 8:667-672, 1978.

58.

Peeples E. , Boswick JA , Scott FA : Wounds of the hand contaminated by human and animal saliva. J Trauma 20:383-389, 1980

59.

Callaham ML : Treatment of common dog bites: infection risk factors. JACEP 7:83-87,1978

60.

Lee M. , Buhr A. : Dog bites and local infections with Pasteurella septica. Br Med J 1:169-171, 1960

61.

Trott A. : Care of mammalian bites. Pediatr Infect Dis J 6:8-10, 1987

62.

Martin LT : Human bites. Guidelines for prompt evaluation and treatment. Postgrad Med 81:221-224,1987 63. Callaham ML : Prophylactic antibiotics in common dog bite wounds: A controlled study. Ann Emerg Med 9:410-414,1980

63.

Goldstein Ejc : Bites, in Mandell GL , Douglas RG , Bennett JE (eds): Principle and Practice of Infectious Diseases, (ed 3). New York, NY, Churchill Livingstone, 1990, pp 834-837

64.

Elenbass RM , McNaoney WK , Robinson WA : Prophylactic oxacillin in dog bite wounds . Ann Emerg Med 11:248-251, 1982

65.

Elliot DL , Tolle SW , Goldberg L. , et al: Pet-associated illness. N Engl J Med 313:985-995,1985

66.

Goldstein E. , Citron DM , Richwals GA : Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida . Antimicrob Agents Chemother 32:213-215, 1988

67.

Holst E. , Roliof J. , Miorner H. : In vitro activities of cefcanel and some other cephalosporins against Pasteurella multocida. Antimicrob Agents Chemother 33:2142-2143, 1989

68.

Goldstein EJ , Reinhardt JF , Murray PM , et al: Outpatient therapy of bite wounds. Demographic data, bacteriology, and a prospective, randomized trial of amoxicillin/clavulanic acid versus penicillin ± dicloxacillin. Int J Dermatol 26:123-127, 1987

69.

Centers for Disease Control, Advisory Committee : Diphtheria tetanus, and pertussis guidelines for vaccine prophylaxis and other preventive measures. Ann Intern Med 95:723-728, 1981 1

70.

Goldstein E. , Gombert M. , Agyare E. : Susceptibility of Eikenella corrodens to newer beta-Iactam antibiotics. Antimicrob Agents Chemothr 18:832-833,1980

71.

Dinerstein C. , Mason R. , Giron F. : Lower extremity complications of diabetes mellitus. Surg Rounds 7:26-41, 1984

72.

Gocke T. : Infections complicating diabetes mellitus, in Grieco M (ed): Infections in the Abnormal Host. New York, NY, Yorke Medical Books, 1982, pp 585-600

73.

Levin M. , Boniuk I. , Anderson C. , et al: Prevention and treatment of diabetic complications. Arch Intern Med 140:691-696, 1980

74.

Wheat LJ , Allen SD , Henry M. , et al: Diabetic foot infections: Bacteriologic analysis. Arch Intern Med 146:1935 -1940,1986

75.

Scher KS , Steele FJ : The septic foot in patients with diabetes. Surgery 104:661-666, 1988

76.

Bamberger DM , Gerding DN : Osteomyelitis in the feet of diabetic patients: Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy. Am J Med 83:653-660,1987

77.

LeFrock JL , Johnson ES , Smith LG , et al: Noncomparative trial of ticarcillin plus clavulanic acid in skin and soft tissue infections. Am J Med 79:122-125, 1985 (suppl 5B)

78.

Tan JS , File TM , Satstrom SJ : Timentin versus moxalactam in the treatment of skin and soft.tissue infections . Am J Med 79:130-133,1985 (suppl 5B)

79.

Sharp CS , Bessman AN , Wagner FW , et al: Microbiology of deep and superficial tissues in infected diabetic gangrene. Surg Gynecol Obstet 149:217-219, 1979

80.

Sapico FL , Witte JL , Canawati HN , et al: The infected foot of the diabetic patient: Quantitative microbiology and analysis of clinical features. Rev Infect Dis 62:S171-S176, 1984 (suppl 1)

81.

Leichter SB , Allweiss P. , Harley J. , et al: Clinical characteristics of diabetic patients with serioius pedal infections. Metabolism 2:22-24,1988 (suppl 1)

82.

Waldvogel FA , McDoff G. , Swartz MN : Osteomyelitis: A review of clinidal features, therapeutic considerations and unusual aspects. N Engl J Med 282:198-216, 1970

83.

Calhoun JH , Eng M. , Cantrell J. , et al: Treatment of diabetic foot infections: Wagner classification, therapy, and outcome. Foot Ankle 9:101-106, 1988

84.

Calandra GB , Raupp W. , Brown KR : Imipenem/ cilastatin treatment of lower extremity skin and soft tissue infections in diabetics. Scand J Infect Dis 52:15-19, 1987 (suppl)

85.

LeFrock JL , Joseph WS : Lower extremity infections in diabetics. Infect Surg 3:135-145,1986

86.

Rayfield EJ , Ault MJ , Keusch GT , et al: Infection and diabetes: The case for glucose control. Am J Med 72:439-450, 1982

87.

Johnson CC , Reinhardt JF , Wallace SL : Safety and efficacy of ticarcillin plus clawlanic acid in the treatment of infections of soft tissue, bone, and joint. Am J Med 79:136-140, 1985 (suppl 5B)

88.

Pankey GA , Katner HP , Valainis GT , et al: Overview of bacterial infections of the skin and soft tissue and clinical experience with ticarcillin plus clawlanate potassium in their treatment. Am J Med 79:106-115, 1985 (suppl 5B)

89.

Rao B. , See RC , Chuah SK , et al: Ticarcillin plus clawlanic acid versus moxalactam in the treatment of skin and soft tissue infections. Am J Med 79:126-129, 1985 (supp15B)

90.

Chiodini PL , Toop MJ , Odugbesan O. , et al: Sulbactam/ampiciilin: Effects on glucose metabolism in diabetics with soft tissue infection. J Antimicrob Chemother 16:643-647,1985

91.

Eron LJ , Harvey L. , Hixon DL , et al: Ciprofloxacin therapy of infections caused by Pseudomonas aeruginosa and other resistant bacteria. Antimicrob Agents Chemother 28:308-310, 1985

92.

Scully BE , Neu HC , Parry MF , et al: Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa, Lancet 1:819-822, 1986

93.

Valainis GT , Pankey GA , Katner HP , et al: Ciprofloxacin in the treatment of bacterial skin infections. Am J Med 82:230-232, 1987 (suppl 4A)

94.

Parish LC , Aten EM : Treatment of skin and skin structure infections: A comparative study of Augmentin and cefaclor. Cutis 34:567-570, 1984

95.

Pien FD : Double-blind comparative study of two dosage regimens of cefactor and amoxacillin-clawlanic acid in the outpatient treatment of soft tissue infections. Antimicrob Agents Chemother 24:856-859, 1983